Skip to main content

Day: December 15, 2023

Roche named among top three most sustainable healthcare companies in the Dow Jones Sustainability Indices

Roche named among top three most sustainable healthcare companies in the Dow Jones Sustainability IndicesThe ranking acknowledges Roche’s commitment to sustainability as an integral part of its business strategy Roche performed particularly well in innovation management, access to healthcare, greenhouse gas emissions, water management, resource efficiency and circularity, labour practice indicators and human rights This marks the 15th consecutive year that Roche has maintained its leading rankingBasel, 15 December 2023 – Roche (SIX: RO, ROG; OTCQX: RHHBY) has again been recognised as one of the most sustainable companies in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). Roche ranked third, Chugai Pharmaceuticals, a member of the Roche Group, ranked second. “We are extremely proud that our deep commitment...

Continue reading

E-SUV Market Share, Size, Trends and Global Industry Growth Analysis Forecast Report [2030]

The Global e-SUV Market to Grow at a CAGR of 14.1% During 2023-2030; Growing Strategic Partnerships by Key Players to Boost Market Growth Pune, India., Dec. 15, 2023 (GLOBE NEWSWIRE) — E-SUV Market The global e-SUV market size was valued at USD 176.67 billion in 2022. The market is projected to grow from USD 208.50 billion in 2023 to USD 524.26 billion by 2030, exhibiting a CAGR of 14.1% during the forecast period. e-SUV, an electric SUV, is a fully-electric sports utility vehicle powered by electricity instead of internal combustion fuel engine. Electric SUVs are one of the most popular electric vehicles, offering zero-emission and quiet operation. The increasing adoption of fuel-efficient mobility solutions is expected to boost market growth during the forecast period. E-SUV Market Drivers & Restraints- Decreasing Electric...

Continue reading

Thomas Erne becomes new Chief Financial Officer of the Feintool Group

Ad hoc announcement pursuant to Art. 53 LR The Board of Directors of Feintool International Holding AG has appointed Thomas Erne as the new CFO and member of the Executive Committee effective April 1, 2024. A proven financial expert with many years of experience as the CFO of listed international companies, he succeeds Samuel Künzli, who will leave Feintool at the end of March 2024. Thomas Erne (50) can look back on a long career as a finance specialist in international industrial companies. Most recently, he was CFO and Head of Corporate Center of the Starrag Group. In this position, he played a key role in the restructuring of Starrag, reducing costs and increasing profitability leading up to the successful fusion with Tornos. Prior to that, he held senior finance positions at the German-Japanese machine tool manufacturer DMG MORI and...

Continue reading

SIKA OPENS A CUTTING-EDGE TECHNOLOGY CENTER IN CHINA

SIKA OPENS A CUTTING-EDGE TECHNOLOGY CENTER IN CHINA Sika has significantly expanded its research and development capacities in the Asia/Pacific region and opened a new, state-of-the-art Technology Center in Suzhou, China. The primary focus of this center is the development of sustainable and high-performance technologies with which Sika makes a significant contribution to the transformation of the construction and automotive industries. The new center of excellence will play a key role in tapping market potential throughout the Asia/Pacific region. The investment volume is in the double-digit millions (CHF). After the center in Zurich, the new Technology Center Suzhou, near Shanghai, is Sika’s second-largest technology center, offering roughly 9,000 square meters of usable space. Approximately 150 experts at the center will be actively...

Continue reading

Press Release: EMA gives positive opinion to Fexinidazole Winthrop as first oral treatment of acute form of sleeping sickness (rhodesiense) found in East and Southern Africa

  EMA gives positive opinion to Fexinidazole Winthrop as first oral treatment of acute form of sleeping sickness (rhodesiense) found in East and Southern Africa Paris, Geneva and Nairobi. December 15, 2023. Sanofi, DNDi and the HAT-r-ACC consortium announce the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive scientific opinion of Fexinidazole Winthrop as first oral treatment of acute form of sleeping sickness (rhodesiense). This positive opinion is for the treatment in adults and children six years of age or older and weighing at least 20 kg, of both first-stage (haemo-lymphatic) and second-stage (meningo-encephalitic) Trypanosoma brucei (T.b.) rhodesiense sleeping sickness, an acute and lethal form of this parasitic disease found in Eastern and Southern Africa. This CHMP...

Continue reading

Electric Vehicle Battery Housing Market Size, Share, Growth And Industry Trends Analysis Forecast Report [2030]

Global Electric Vehicle (EV) Battery Housing Market Analysis By Vehicle Type, Material, and Regional Forecast [2023-2030] Pune, India., Dec. 15, 2023 (GLOBE NEWSWIRE) — Electric Vehicle Battery Housing Market Size The global Electric Vehicle (EV) battery housing market size was USD 9.31 billion in 2022. The market is set to rise from USD 11.80 billion in 2023 to USD 28.40 billion by 2030 at a CAGR of 13.4% during 2023-2030. Electric Vehicle (EV) battery housing is a specially developed box for batteries, including the lithium-ion battery of an electric vehicle. Increasing demand for EV battery housing to safeguard the battery cell from damage and environmental factors, including moisture, dust, and debris is driving market expansion. Electric Vehicle Battery Housing Market Drivers & Restraints- Rising Need for Improved Safety...

Continue reading

Novel Clinic Assets OÜ has filed a lawsuit against Hepsor P113 OÜ, an affiliate of Hepsor AS.

Hepsor P113 OÜ, an affiliate of Hepsor AS with a 45% shareholding, terminated the lease agreement with Novel Clinic Assets OÜ. Hepsor P113 OÜ owns a commercial building with a leasable area of ca 4,000 m2 in Tallinn, at Pärnu mnt 113, of which the terminated lease agreement was signed for 3,575 m2. The lease was terminated due to a significant and continuous violation of lease terms by the tenant. Hepsor P113 OÜ has submitted a claim for damages amounting to approximately 3 million euros against the tenant. On November 9th, Novel Clinic Assets OÜ filed a lawsuit with Harju County Court to restore the lease agreement for Pärnu mnt 113, seek compensation for the termination of the lease agreement, and reclaim the property left in the premises. According to Hepsor P113 OÜ’s lawyer, the claims made by the plaintiff are unfounded, as...

Continue reading

Bayview Acquisition Corp Announces Pricing of Upsized $60 Million Initial Public Offering

Cayman Islands, Dec. 14, 2023 (GLOBE NEWSWIRE) — Bayview Acquisition Corp (the “Company”) today announced the pricing of its upsized initial public offering of 6,000,000 units at a price of $10.00 per unit. The units will be listed on the Nasdaq Stock Market LLC (“Nasdaq”) and trade under the ticker symbol “BAYAU” beginning on December 15, 2023. Each unit consists of one ordinary share and one right, with each right entitling the holder thereof to receive one-tenth of one ordinary share upon consummation of an initial business combination. After the securities comprising the units begin separate trading, the ordinary shares and rights are expected to be listed on Nasdaq under the symbols “BAYA” and “BAYAR,” respectively. The offering is expected to close on December 19, 2023, subject to customary closing conditions. Bayview Acquisition...

Continue reading

Rogers Sugar Responds to Union Rejection of Global Proposal

VANCOUVER, British Columbia, Dec. 14, 2023 (GLOBE NEWSWIRE) — Rogers Sugar Inc. (the “Company” or “Rogers Sugar”) (TSX: RSI) today announced that the Public and Private Workers of Canada (PPWC) Local 8 representing workers at the Company’s Vancouver refinery has rejected the latest global proposal by the Company. The Company provided the following statement: “Rogers Sugar has repeatedly communicated to the union that continuous operation at the Vancouver refinery is essential to preserve and create jobs, meet growing market demand, and to ensure the future of the plant. The status quo is simply not an option. Unfortunately, the parties have not been able to come to an agreement on the fact that, to survive in the long term, the plant needs to move to continuous operation. We have put forward our best efforts to resolve the current...

Continue reading

Alpha Lithium Shareholders Approve the Privatization of Alpha Lithium by Tecpetrol

VANCOUVER, British Columbia, Dec. 14, 2023 (GLOBE NEWSWIRE) — Alpha Lithium Corporation (NEO: ALLI) (OTC: APHLF) (German WKN: A3CUW1) (“Alpha”) is pleased to announce that, at the special meeting (the “Meeting”) of holders of common shares of Alpha (“Alpha Shareholders”) held earlier today, Alpha Shareholders approved the privatization of Alpha pursuant to the amalgamation (the “Amalgamation”) of Alpha and 1446978 B.C. Ltd. (“Purchaser Subco”), a direct wholly-owned subsidiary of TechEnergy Lithium Canada Inc. (the “Purchaser”) and an indirect wholly-owned subsidiary of Tecpetrol Investments S.L., under the provisions of the Business Corporations Act (British Columbia). The Amalgamation constitutes the subsequent acquisition transaction contemplated by the offer (the “Offer”) of the Purchaser to acquire all of the issued and outstanding...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.